Evidence map›Paper›PMID 23933793›Full record

ReviewCurrent hypertension reports2013

Hypertension after kidney transplantation: a pathophysiologic approach.

Beje Thomas, David J Taber, Titte R Srinivas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. A Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Understanding the Two Faces of Low-Salt Intake.Current hypertension reports · 2017
    Review
  7. Hypertension in kidney transplantation is associated with an early renal nerve sprouting.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2017
    Article
  8. Hypertension in the Pediatric Intensive Care Unit.Journal of pediatric intensive care · 2016
    Review
  9. Review
  10. Assessment and management of hypertension in transplant patients.Journal of the American Society of Nephrology : JASN · 2015
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Beje ThomasDivision of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas Street CSB 829, Charleston, SC, 29425, USA, thombeje@musc.edu.
David J Taber
Titte R Srinivas
Medical University of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-transplant hypertension is associated with decreased graft and patient survival and cardiovascular morbidity. Unfortunately, post-transplant hypertension is often poorly controlled. Important risk factors include immunosuppressive medications, complications of the transplant surgery, delayed graft function, rejection, and donor and recipient risk factors. The effects of immunosuppressive medications are multifactorial including increased vascular and sympathetic tone and salt and fluid retention. The immunosuppressive agents most commonly associated with hypertension are glucocorticoids and calcineurin inhibitors. Drug therapy for hypertension should be based on the comorbidities and pathophysiology. Evidence-based approaches to defining and treating hypertension in renal transplant recipients are predominantly extrapolated from large-scale studies performed in the general population. Thus, there continues to be a need for larger studies examining the pathophysiology, diagnosis and treatment of hypertension in renal transplant recipients.

Indexed as

AnimalsAntihypertensive AgentsHumansHypertensionImmunosuppressive AgentsKidney TransplantationRisk FactorsTreatment OutcomeAntihypertensive AgentsImmunosuppressive Agents

Identifiers

PMID23933793
OpenAlexW2003706178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.